Cargando…
Advances in pathogenesis and treatment of essential hypertension
Hypertension is a significant risk factor for cardiovascular and cerebrovascular diseases and the leading cause of premature death worldwide. However, the pathogenesis of the hypertension, especially essential hypertension, is complex and requires in-depth studies. Recently, new findings about essen...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616110/ https://www.ncbi.nlm.nih.gov/pubmed/36312252 http://dx.doi.org/10.3389/fcvm.2022.1003852 |
_version_ | 1784820578486583296 |
---|---|
author | Ma, Jun Chen, Xiaoping |
author_facet | Ma, Jun Chen, Xiaoping |
author_sort | Ma, Jun |
collection | PubMed |
description | Hypertension is a significant risk factor for cardiovascular and cerebrovascular diseases and the leading cause of premature death worldwide. However, the pathogenesis of the hypertension, especially essential hypertension, is complex and requires in-depth studies. Recently, new findings about essential hypertension have emerged, and these may provide important theoretical bases and therapeutic tools to break through the existing bottleneck of essential hypertension. In this review, we demonstrated important advances in the different pathogenesis areas of essential hypertension, and highlighted new treatments proposed in these areas, hoping to provide insight for the prevention and treatment of the essential hypertension. |
format | Online Article Text |
id | pubmed-9616110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96161102022-10-29 Advances in pathogenesis and treatment of essential hypertension Ma, Jun Chen, Xiaoping Front Cardiovasc Med Cardiovascular Medicine Hypertension is a significant risk factor for cardiovascular and cerebrovascular diseases and the leading cause of premature death worldwide. However, the pathogenesis of the hypertension, especially essential hypertension, is complex and requires in-depth studies. Recently, new findings about essential hypertension have emerged, and these may provide important theoretical bases and therapeutic tools to break through the existing bottleneck of essential hypertension. In this review, we demonstrated important advances in the different pathogenesis areas of essential hypertension, and highlighted new treatments proposed in these areas, hoping to provide insight for the prevention and treatment of the essential hypertension. Frontiers Media S.A. 2022-10-14 /pmc/articles/PMC9616110/ /pubmed/36312252 http://dx.doi.org/10.3389/fcvm.2022.1003852 Text en Copyright © 2022 Ma and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Ma, Jun Chen, Xiaoping Advances in pathogenesis and treatment of essential hypertension |
title | Advances in pathogenesis and treatment of essential hypertension |
title_full | Advances in pathogenesis and treatment of essential hypertension |
title_fullStr | Advances in pathogenesis and treatment of essential hypertension |
title_full_unstemmed | Advances in pathogenesis and treatment of essential hypertension |
title_short | Advances in pathogenesis and treatment of essential hypertension |
title_sort | advances in pathogenesis and treatment of essential hypertension |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616110/ https://www.ncbi.nlm.nih.gov/pubmed/36312252 http://dx.doi.org/10.3389/fcvm.2022.1003852 |
work_keys_str_mv | AT majun advancesinpathogenesisandtreatmentofessentialhypertension AT chenxiaoping advancesinpathogenesisandtreatmentofessentialhypertension |